1-[5-(1H-Indol-2-yl)-2-methoxy-phenyl]-3-(1-phenyl-ethyl)-thiourea | 381217-18-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1-[5-(1H-Indol-2-yl)-2-methoxy-phenyl]-3-(1-phenyl-ethyl)-thiourea
• 英文别名: 1-[5-(1H-indol-2-yl)-2-methoxyphenyl]-3-(1-phenylethyl)thiourea
• CAS: 381217-18-1
• 化学式: C₂₄H₂₃N₃OS
• 分子量: 401.532
• InChiKey: PNDGMJQDXNKFJR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  81.2
• 氢给体数：
  3
• 氢受体数：
  2

文献信息

• Novel potassium channels modulators
  申请人：Garcia Gabriel

  公开号：US20050070570A1

  公开（公告）日：2005-03-31

  The invention relates to compounds having the Formula (I) or a salt, or a physiologically functional derivative, or a prodrug thereof, wherein Z is carbonyl or sulfonyl; R 1 is alkyl, alkenyl, alkynyl, aryl, H, halogen, haloalkyl, haloalkoxy, hydroxyalkyl, cycloalkyl or heteroaryl; R 2 is H, OH, —CH 2 —SO 2 -alkyl, —CH 2 —SO 2 -cycloalkyl, —CH 2 —SO 2 -aryl, —CH 2 —SO 2 -heteroaryl, alkylamine, alkenylamine, alkynylamine, cycloalkylamine, arylamine, heteroarylamine, aryl, haloalkyl, haloalkoxy, hydroxyalkyl, cycloalkyl, heteroaryl or a linear or branched alkyl, alkenyl, alkynyl, which can optionally be substituted by one or more substituents R 3 ; R 3 is H, alkyl, alkenyl, alkynyl, cycloalkyl, —CO 2 R 4 , —CONHR 4 , —CONR 4 R 4 , —CR 4 O, —SO 2 R 4 , —NR 4 —CO—R 4 , alkoxy, alkylthio, —OH, —SH, —O-aryl, —O-cycloalkyl, —S-aryl, —S-cycloalkyl, hydroxyalkyl, halogen, haloalkyl, haloalkoxy, CN, NO 2 , hydroxyalkylamine, aminoalkyl, alkylamine, aryl or heteroaryl; R 4 is H, halogen, alkyl, alkenyl, alkynyl, cycloalkyl, alkoxy, alkylthio, —O-aryl, —O-cycloalkyl, OH, SH, —S-aryl, —S-cycloalkyl, hydroxyalkyl, haloalkyl, haloalkoxy, hydroxyalkyl-amine, aminoalkyl, alkylamine, aryl or heteroaryl; R 5 is alkyl, alkenyl or alkynyl.

  该发明涉及具有式（I）的化合物或其盐，或其生理功能衍生物，或其前药，其中Z为羰基或磺酰基；R1为烷基，烯烃基，炔烃基，芳基，氢，卤素，卤代烷基，卤代甲氧基，羟基烷基，环烷基或杂环芳基；R2为氢，羟基，—CH2—SO2-烷基，— —SO2-环烷基，— —SO2-芳基，— —SO2-杂环芳基，烷基胺，烯烃基胺，炔烃基胺，环烷基胺，芳基胺，杂环芳基胺，芳基，卤代烷基，卤代甲氧基，羟基烷基，环烷基，杂环芳基或一个线性或支链烷基，烯烃基，炔烃基，可以选择地被一个或多个取代基R3取代；R3为氢，烷基，烯烃基，炔烃基，环烷基，—CO2R4，—CONHR4，—CONR4R4，—CR4O，—SO2R4，—NR4—CO—R4，烷氧基，烷基硫醚，—羟基，—硫氢，—O-芳基，—O-环烷基，—S-芳基，—S-环烷基，羟基烷基，卤素，卤代烷基，卤代甲氧基，CN，NO2，羟基烷胺，氨基烷基，烷基胺，芳基或杂环芳基；R4为氢，卤素，烷基，烯烃基，炔烃基，环烷基，烷氧基，烷基硫醚，—O-芳基，—O-环烷基，羟基，硫氢，—S-芳基，—S-环烷基，羟基烷基，卤代烷基，卤代甲氧基，羟基烷胺，氨基烷基，烷基胺，芳基或杂环芳基；R5为烷基，烯烃基或炔烃基。
• Indole and benzimidazole 15-lipoxygenase inhibitors
  申请人：——

  公开号：US20040038943A1

  公开（公告）日：2004-02-26

  This invention provides indole and benzimidazole 15-lipoxygenase (15-LO) inhibitors of the formula where one of Y 1 and Y 2 is CH, N, or NH, and the other is R 3 includes H, halo. HN 2 , COOH, alkyl; R 4 includes halo, alkyl, and alkoxy; Z is C, CH, or NR 5 ; R 5 is H or oxycabonyl; and each X is independently H, alkyl, alkoxy, or halo. 1

  这项发明提供了一种公式的吲哚和苯并咪唑15-脂氧化酶（15-LO）抑制剂，其中Y1和Y2中的一个是CH、N或NH，另一个是R3包括H、卤素、HN2、COOH、烷基；R4包括卤素、烷基和烷氧基；Z是C、CH或NR5；R5是H或氧羰基；每个X独立地是H、烷基、烷氧基或卤素。
• INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP1294686A2

  公开（公告）日：2003-03-26
• US6858739B2
  申请人：——

  公开号：US6858739B2

  公开（公告）日：2005-02-22
• [EN] INDOLE AND BENZIMIDAZOLE 15-LIPOXYGENASE INHIBITORS<br/>[FR] INDOLS ET BENZIMIDAZOLES CONSTITUANT DES INHIBITEURS DE 15-LIPOXYGENASE
  申请人：WARNER LAMBERT CO

  公开号：WO2001096299A2

  公开（公告）日：2001-12-20

  This invention provides indole and benzimidazole 15-lipoxygenase (15-LO) inhibitors of the formula where one of Y1 and Y2 is CH, N, or NH, and the other is R3 includes H, halo, HN2, COOH, alkyl; R4 includes halo, alkyl, and alkoxy; Z is C, CH, or NR5; R5 is H or oxycabonyl; and each X is independently H, alkyl, alkoxy, or halo.